Article: A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis

The therapeutic efficacy of the immunomodulator OM-8980 in rheumatoid arthritis was compared with that of auranofin, an oral gold salt, in a double blind, randomised multicentre study lasting six months. Seventy patients were treated with auranofin and 75 with OM-8980. The patients of both groups improved significantly at three and six months for all the clinical parameters observed: Ritchie index, number of swollen joints, morning stiffness, pain, grip strength, intake of non-steroidal anti-inflammatory drugs, and erythrocyte sedimentation rate. No serious side effects were observed in either group. The patients receiving auranofin had more adverse reactions, mainly affecting the gastrointestinal system.

Citing Articles

Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis: A Network Meta-Analysis.

Guski L, Jurgens G, Pedder H, Levinsen N, Andersen S, Welton N JAMA Netw Open. 2023; 6(10):e2335950.

PMID: 37801318 PMC: 10559183. DOI: 10.1001/jamanetworkopen.2023.35950.

Oral desensitisation in rheumatoid arthritis.

Vischer T, van Eden W Ann Rheum Dis. 1994; 53(11):708-10.

PMID: 7826130 PMC: 1005445. DOI: 10.1136/ard.53.11.708.

Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally-induced tolerance?.

Polla B, Baladi S, Fuller K, Rook G Experientia. 1995; 51(8):775-9.

PMID: 7649235 DOI: 10.1007/BF01922429.

Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.

Hauzeur J, Appelboom T Rheumatol Int. 1989; 9(2):71-6.

PMID: 2682980 DOI: 10.1007/BF00270248.

Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.

Vischer T Clin Rheumatol. 1990; 9(3):356-61.

PMID: 2261735 DOI: 10.1007/BF02114396.

References

1.

Ritchie D, Boyle J, McInnes J, Jasani M, Dalakos T, Grieveson P . Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968; 37(147):393-406. View

2.

Huskisson E . Measurement of pain. Lancet. 1974; 2(7889):1127-31. DOI: 10.1016/s0140-6736(74)90884-8. View

3.

Zubler R, Nydegger U, Perrin L, Fehr K, McCormick J, Lambert P . Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest. 1976; 57(5):1308-19. PMC: 436784. DOI: 10.1172/JCI108399. View

4.

Lewi P, Symoens J . Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study. J Rheumatol Suppl. 1978; 4:17-25. View

5.

Messerli C, Michetti F, SAUSER-HALL P, STAUBLI C, Taddei M, Weiss S . [Effect of a bacterial lysate (Broncho-Vaxom) in the therapy of chronic bronchitis: multi-center double-blind clinical trial]. Rev Med Suisse Romande. 1981; 101(2):143-6. View

6.

. 1958 REVISION of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum. 1959; 2(1):16-20. DOI: 10.1002/1529-0131(195902)2:1<16::aid-art1780020104>3.0.co;2-9. View

7.

Wenger M, Alexander S, Bland J, Blechman W . Auranofin versus placebo in the treatment of rheumatoid arthritis. Am J Med. 1983; 75(6A):123-7. DOI: 10.1016/0002-9343(83)90484-9. View

8.

Keller R, Hinz G . [Effect of an oral polyvalent bacterial lysate (Broncho-Vaxom) in chronic bronchitis]. Prax Klin Pneumol. 1984; 38(6):225-8. View

9.

Thompson P, Jones D, Currey H . Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis. Ann Rheum Dis. 1986; 45(1):9-14. PMC: 1001807. DOI: 10.1136/ard.45.1.9. View

10.

Rosenthal M . Effect of a bacterial extract on cellular and humoral immune responses in humans. J Immunopharmacol. 1986; 8(3):315-25. DOI: 10.3109/08923978609026492. View

11.

Rheins M, McCOY F, BURRELL R, BUEHLER E . A modification of the latex-fixation test for the study of rheumatoid arthritis. J Lab Clin Med. 1957; 50(1):113-8. View

12.

WARD J, Williams H, Egger M, Reading J, BOYCE E, Samuelson Jr C . Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum. 1983; 26(11):1303-15. DOI: 10.1002/art.1780261102. View

A Double Blind Multicentre Study of OM-8980 and Auranofin in Rheumatoid Arthritis